Activation of the PD-1/PD-L1 signaling pathway inhibits the proliferation and activation of CD4+ T cells and CD8+ T cells, suppresses the expression of cytokines, alters the tumor microenvironment, weakens the body’s surveillance and clearance capabilities against tumor cells, and promotes tumor cells to evade immune surveillance and killing (16). Here, CD4 is linked to neoplasm.